Trinity Biotech Plc Stock Technical Analysis
| TRIB Stock | USD 0.77 0.00 0.000003% |
As of the 16th of February 2026, Trinity Biotech has the Semi Deviation of 5.43, risk adjusted performance of 0.0099, and Coefficient Of Variation of 88492.12. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Trinity Biotech plc, as well as the relationship between them.
Trinity Biotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Trinity, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to TrinityTrinity Biotech's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Trinity Biotech Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 3.0 | Strong Buy | 1 | Odds |
Most Trinity analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Trinity stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Trinity Biotech plc, talking to its executives and customers, or listening to Trinity conference calls.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Biotech. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Trinity Biotech assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.77) | Earnings Share (1.80) | Revenue Per Share | Quarterly Revenue Growth 0.181 | Return On Assets |
Trinity Biotech plc's market price often diverges from its book value, the accounting figure shown on Trinity's balance sheet. Smart investors calculate Trinity Biotech's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Trinity Biotech's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Trinity Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Trinity Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Trinity Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Trinity Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Trinity Biotech.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Trinity Biotech on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Trinity Biotech plc or generate 0.0% return on investment in Trinity Biotech over 90 days. Trinity Biotech is related to or competes with Advanced Biomed, BioNexus Gene, Beyond Air, Marker Therapeutics, SINTX Technologies, Evogene, and Sensei Biotherapeutics. Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laborator... More
Trinity Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Trinity Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Trinity Biotech plc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.69 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 64.13 | |||
| Value At Risk | (8.97) | |||
| Potential Upside | 12.86 |
Trinity Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Trinity Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Trinity Biotech's standard deviation. In reality, there are many statistical measures that can use Trinity Biotech historical prices to predict the future Trinity Biotech's volatility.| Risk Adjusted Performance | 0.0099 | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.62) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.0005) |
Trinity Biotech February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0099 | |||
| Market Risk Adjusted Performance | 0.0095 | |||
| Mean Deviation | 4.75 | |||
| Semi Deviation | 5.43 | |||
| Downside Deviation | 6.69 | |||
| Coefficient Of Variation | 88492.12 | |||
| Standard Deviation | 8.3 | |||
| Variance | 68.91 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.62) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.0005) | |||
| Maximum Drawdown | 64.13 | |||
| Value At Risk | (8.97) | |||
| Potential Upside | 12.86 | |||
| Downside Variance | 44.76 | |||
| Semi Variance | 29.51 | |||
| Expected Short fall | (8.73) | |||
| Skewness | 2.2 | |||
| Kurtosis | 11.71 |
Trinity Biotech plc Backtested Returns
Trinity Biotech appears to be abnormally volatile, given 3 months investment horizon. Trinity Biotech plc owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0261, which indicates the firm had a 0.0261 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Trinity Biotech plc, which you can use to evaluate the volatility of the company. Please review Trinity Biotech's Risk Adjusted Performance of 0.0099, coefficient of variation of 88492.12, and Semi Deviation of 5.43 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Trinity Biotech holds a performance score of 2. The entity has a beta of 1.24, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Trinity Biotech will likely underperform. Please check Trinity Biotech's sortino ratio and the relationship between the potential upside and day median price , to make a quick decision on whether Trinity Biotech's existing price patterns will revert.
Auto-correlation | 0.34 |
Below average predictability
Trinity Biotech plc has below average predictability. Overlapping area represents the amount of predictability between Trinity Biotech time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Trinity Biotech plc price movement. The serial correlation of 0.34 indicates that nearly 34.0% of current Trinity Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.34 | |
| Spearman Rank Test | -0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Trinity Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Trinity Biotech plc Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Trinity Biotech plc volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Trinity Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Trinity Biotech plc on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Trinity Biotech plc based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Trinity Biotech plc price pattern first instead of the macroeconomic environment surrounding Trinity Biotech plc. By analyzing Trinity Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Trinity Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Trinity Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.00337 | 0.001908 | Price To Sales Ratio | 1.48 | 1.4 |
Trinity Biotech February 16, 2026 Technical Indicators
Most technical analysis of Trinity help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Trinity from various momentum indicators to cycle indicators. When you analyze Trinity charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0099 | |||
| Market Risk Adjusted Performance | 0.0095 | |||
| Mean Deviation | 4.75 | |||
| Semi Deviation | 5.43 | |||
| Downside Deviation | 6.69 | |||
| Coefficient Of Variation | 88492.12 | |||
| Standard Deviation | 8.3 | |||
| Variance | 68.91 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.62) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.0005) | |||
| Maximum Drawdown | 64.13 | |||
| Value At Risk | (8.97) | |||
| Potential Upside | 12.86 | |||
| Downside Variance | 44.76 | |||
| Semi Variance | 29.51 | |||
| Expected Short fall | (8.73) | |||
| Skewness | 2.2 | |||
| Kurtosis | 11.71 |
Trinity Biotech February 16, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Trinity stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.06 | ||
| Daily Balance Of Power | 0.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 0.79 | ||
| Day Typical Price | 0.78 | ||
| Price Action Indicator | (0.02) | ||
| Market Facilitation Index | 0.05 |
Complementary Tools for Trinity Stock analysis
When running Trinity Biotech's price analysis, check to measure Trinity Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trinity Biotech is operating at the current time. Most of Trinity Biotech's value examination focuses on studying past and present price action to predict the probability of Trinity Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trinity Biotech's price. Additionally, you may evaluate how the addition of Trinity Biotech to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |